J Breast Cancer.  2011 Sep;14(3):219-222.

The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty

• Dogan L
• Gulcelik M
• Bulut M
• Karaman N
• Kiziltan G
• Ozaslan C

Abstract

PURPOSE
This study evaluated the importance of routine pathological examination of contralateral breast specimens in breast cancer patients using reduction mammoplasty.
METHODS
Theweight of breast tissue resected from the contralateral breast in 71 patients and the number of slices used for pathological evaluation were recorded. Breast lesions found in the contralateral breast and accompanying lesions with tumors were examined.
RESULTS
High risk proliferative lesions were reported in the contralateral breast of eight (11.2%) patients, and low-risk lesions were detected in 18 (25%). While the mean age of the patients with high-risk lesions was 45.6, it was 52.8 for the other patients (p=0.036).
CONCLUSION
Bilateral reduction mammoplasty may be beneficial to delineate some pathologies in contralateral breasts even in those patients with normal clinical and radiological findings. The incidental discovery of these pathologies is much more likely in young breast cancer patients.

Keyword

Breast neoplasms; Contralateral; Mammoplasty

MeSH Terms

Breast
Breast Neoplasms
Female
Humans
Incidental Findings
Mammaplasty

Reference

1. Caruso F, Catanuto G, De Meo L, Ferrara M, Gallodoro A, Petrolito E, et al. Outcomes of bilateral mammoplasty for early stage breast cancer. Eur J Surg Oncol. 2008. 34:1143–1147.

2. Achard E, Salmon RJ. Reduction mammoplasty in breast cancers of the lower quadrants. Bull Cancer. 2007. 94:225–228.

3. Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients. Plast Reconstr Surg. 2009. 124:1033–1039.

4. Colwell AS, Kukreja J, Breuing KH, Lester S, Orgill DP. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience. Plast Reconstr Surg. 2004. 113:1984–1988.

5. Bondeson L, Linell F, Ringberg A. Breast reductions: what to do with all the tissue specimens? Histopathology. 1985. 9:281–285.

6. Ambaye AB, MacLennan SE, Goodwin AJ, Suppan T, Naud S, Weaver DL. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Plast Reconstr Surg. 2009. 124:1386–1392.

7. Petit JY, Rietjens M, Contesso G, Bertin F, Gilles R. Contralateral mastoplasty for breast reconstruction: a good opportunity for glandular exploration and occult carcinomas diagnosis. Ann Surg Oncol. 1997. 4:511–515.

8. Ishag MT, Bashinsky DY, Beliaeva IV, Niemann TH, Marsh WL Jr. Pathologic findings in reduction mammaplasty specimens. Am J Clin Pathol. 2003. 120:377–380.

9. Wanebo HJ, Senofsky GM, Fechner RE, Kaiser D, Lynn S, Paradies J. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg. 1985. 201:667–677.

10. Hankey BF, Curtis RE, Naughton MD, Boice JD Jr, Flannery JT. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst. 1983. 70:797–804.

11. Lesser ML, Rosen PP, Kinne DW. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982. 91:234–240.

12. Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. Am J Epidemiol. 1992. 136:937–948.

13. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995. 56:265–271.

14. Smith BL, Bertagnolli M, Klein BB, Batter S, Chang M, Douville LM, et al. Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer. Ann Surg. 1992. 216:17–21.

15. Ricci MD, Munhoz AM, Pinotti M, Geribela AH, Teixeira LC, Aldrighi C, et al. The influence of reduction mammaplasty techniques in synchronous breast cancer diagnosis and metachronous breast cancer prevention. Ann Plast Surg. 2006. 57:125–132.

16. Brinton LA, Persson I, Boice JD Jr, McLaughlin JK, Fraumeni JF Jr. Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer. 2001. 91:478–483.

17. Tabár L, Dean PB. Basic principles of mammographic diagnosis. Diagn Imaging Clin Med. 1985. 54:146–157.